Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Transition Therapeutics and Elan modify ELND-005 collaboration agreement

Dec. 28, 2010

Pro-Pharmaceuticals and Mount Sinai School of Medicine to evaluate galectin-targeting agents

Dec. 28, 2010

Meda obtains rights to market EpiPen auto-injector in Europe

Dec. 27, 2010

Novo Nordisk and Emisphere to develop oral insulin for diabetes

Dec. 23, 2010

GSK and Impax collaborate on late-stage Parkinson's disease therapeutic

Dec. 21, 2010

Bristol-Myers Squibb and Oncolys sign licensing agreement for festinavir

Dec. 21, 2010

Lpath enters into an option license agreement with Pfizer for iSONEP

Dec. 21, 2010

Recordati and Nymox sign licensing agreement for NX-1207 in BPH

Dec. 20, 2010

Adimab to collaborate with Lilly, Genentech and Human Genome Sciences

Dec. 17, 2010

Lundbeck, Zenobia and Vernalis to codevelop dardarin inhibitors

Dec. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...